Literature DB >> 25496217

TLR4 and NALP3 inflammasome in the development of endothelial dysfunction in uraemia.

Susana Martin-Rodriguez1, Carolina Caballo, Gabriela Gutierrez, Manel Vera, Josep M Cruzado, Aleix Cases, Gines Escolar, Maribel Diaz-Ricart.   

Abstract

BACKGROUND: The increased cardiovascular risk present in chronic kidney disease (CKD) is related to the development of endothelial dysfunction, whose mechanisms are still unclear. Accumulation of toxins and proinflammatory cytokines may constitute danger-associated molecular patterns (DAMP) to which endothelial cells are continuously exposed. Potential involvement of mechanisms recognizing DAMP, such as TLR and inflammasomes, has been explored.
MATERIALS AND METHODS: Endothelial cells in culture were exposed to sera samples collected from patients with CKD: (i) stages 4-5 not on dialysis (PreD), (ii) on maintenance haemodialysis (HD) and (iii) peritoneal dialysis (PD). Changes in TLR4 and ICAM-1 expression, reactive oxygen species (ROS) production and TLR4 signalling were explored. Assembly of NALP3 inflammasome components was also investigated.
RESULTS: TLR4 was expressed at the cell surface and increased significantly in response to PreD, HD and PD sera, paralleling with the activation of the cell stress protein Akt and the inflammation-related transcription factor NFκB, with elevated surface ICAM-1 expression and ROS production. TLR4 blockade partially decreased these effects. Exposure of cells to uraemic sera induced assembly of NALP3 components, with caspase-1 activation, especially in response to HD and PD sera.
CONCLUSIONS: TLR4 and NALP3 inflammasomes, crucial elements of innate immunity, contribute to the development and perpetuation of endothelial dysfunction in response to the uraemic toxicity. These mechanisms constitute potential therapeutic targets to improve endothelial dysfunction and to reduce the increased cardiovascular risk in CKD.
© 2014 Stichting European Society for Clinical Investigation Journal Foundation.

Entities:  

Keywords:  Chronic kidney disease; NALP3; TLR4; endothelial dysfunction; innate immunity; uraemia

Mesh:

Substances:

Year:  2015        PMID: 25496217     DOI: 10.1111/eci.12392

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  23 in total

1.  What is going on between defibrotide and endothelial cells? Snapshots reveal the hot spots of their romance.

Authors:  Marta Palomo; Enrique Mir; Montse Rovira; Ginés Escolar; Enric Carreras; Maribel Diaz-Ricart
Journal:  Blood       Date:  2016-01-11       Impact factor: 22.113

2.  The NLRP3 Inflammasome Has a Critical Role in Peritoneal Dialysis-Related Peritonitis.

Authors:  Nicolas Hautem; Johann Morelle; Amadou Sow; Cyril Corbet; Olivier Feron; Eric Goffin; François Huaux; Olivier Devuyst
Journal:  J Am Soc Nephrol       Date:  2017-02-13       Impact factor: 10.121

Review 3.  An update on the role of the inflammasomes in the pathogenesis of kidney diseases.

Authors:  Murthy N Darisipudi; Felix Knauf
Journal:  Pediatr Nephrol       Date:  2015-07-16       Impact factor: 3.714

Review 4.  Inflammasomes link vascular disease with neuroinflammation and brain disorders.

Authors:  Nikolett Lénárt; David Brough; Ádám Dénes
Journal:  J Cereb Blood Flow Metab       Date:  2016-08-02       Impact factor: 6.200

Review 5.  Inflammasomes in the Pathophysiology of Kidney Diseases.

Authors:  Humaira Masood; Ruochen Che; Aihua Zhang
Journal:  Kidney Dis (Basel)       Date:  2015-09-04

6.  TLR4-dependent upregulation of the platelet NLRP3 inflammasome promotes platelet aggregation in a murine model of hindlimb ischemia.

Authors:  Sebastian Vogel; Pranav Murthy; Xiangdong Cui; Michael T Lotze; Herbert J Zeh; Ulka Sachdev
Journal:  Biochem Biophys Res Commun       Date:  2018-12-03       Impact factor: 3.575

7.  The platelet NLRP3 inflammasome is upregulated in sickle cell disease via HMGB1/TLR4 and Bruton tyrosine kinase.

Authors:  Sebastian Vogel; Taruna Arora; Xunde Wang; Laurel Mendelsohn; James Nichols; Darlene Allen; Arun S Shet; Christian A Combs; Zenaide M N Quezado; Swee Lay Thein
Journal:  Blood Adv       Date:  2018-10-23

Review 8.  Of Inflammasomes and Alarmins: IL-1β and IL-1α in Kidney Disease.

Authors:  Hans-Joachim Anders
Journal:  J Am Soc Nephrol       Date:  2016-08-11       Impact factor: 10.121

Review 9.  Mechanisms of haemolysis-induced kidney injury.

Authors:  Kristof Van Avondt; Erfan Nur; Sacha Zeerleder
Journal:  Nat Rev Nephrol       Date:  2019-08-27       Impact factor: 28.314

10.  Apixaban Downregulates Endothelial Inflammatory and Prothrombotic Phenotype in an In Vitro Model of Endothelial Dysfunction in Uremia.

Authors:  Sergi Torramade-Moix; Marta Palomo; Manel Vera; Didac Jerez; Ana Belen Moreno-Castaño; M Urooj Zafar; Jordi Rovira; Fritz Diekmann; Joan Carles Garcia-Pagan; Gines Escolar; Aleix Cases; Maribel Diaz-Ricart
Journal:  Cardiovasc Drugs Ther       Date:  2021-06       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.